Continuous Glucose Monitoring in a 71-year-old Man with Diabetes and COVID-19 During an Episode of Cardiac Arrest: Return of Spontaneous Circulation and Subsequent Death
US Endocrinology
; 17(1):10-13, 2021.
Article
in English
| EMBASE | ID: covidwho-1766544
ABSTRACT
We assessed real-time continuous glucose monitoring (rtCGM) data in an individual with type 2 diabetes who presented with severe symptoms of COVID-19, and suffered a fatal cardiac arrest during hospitalization. In this retrospective analysis, we used rtCGM to evaluate changes in blood glucose levels in a 71-year-old male with COVID-19 symptoms who suffered a fatal cardiac arrest. Blood glucose levels remained constant at 220–225 mg/dL after the first cardiac arrest, slowly decreased to 167 mg/dL after return of spontaneous circulation was achieved, and rose to 198 mg/dL prior to the second arrest. After the patient expired, glucose levels decreased to the 141 mg/dL over the first hour, but quickly declined to undetectable levels within the next 20 minutes. Wider adoption of rtCGM use in patients with COVID-19 may help identify blood glucose patterns and uncover new insights to various comorbidities and conditions
adoption; aged; article; blood glucose monitoring; case report; clinical article; comorbidity; coronavirus disease 2019; diabetes mellitus; glucose blood level; heart arrest; hospitalization; human; insulin dependent diabetes mellitus; male; non insulin dependent diabetes mellitus; retrospective study; return of spontaneous circulation
Search on Google
Collection:
Databases of international organizations
Database:
EMBASE
Language:
English
Journal:
US Endocrinology
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS